A share price of Mirum Pharmaceuticals Inc [MIRM] is currently trading at $50.42, up 1.59%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MIRM shares have gain 7.16% over the last week, with a monthly amount glided 11.35%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel started tracking the stock with Buy rating on April 17, 2024, and set its price target to $48. On December 18, 2023, H.C. Wainwright reiterated its Buy rating and revised its price target to $58 on the stock. Morgan Stanley initiated its recommendation with a Overweight and recommended $60 as its price target on November 13, 2023. Cantor Fitzgerald started tracking with a Overweight rating for this stock on October 24, 2023, and assigned it a price target of $50.
Mirum Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $25.73 and $54.23. Currently, Wall Street analysts expect the stock to reach $57.25 within the next 12 months. Mirum Pharmaceuticals Inc [NASDAQ: MIRM] shares were valued at $50.42 at the most recent close of the market. An investor can expect a potential return of 13.55% based on the average MIRM price forecast.
Analyzing the MIRM fundamentals
Trailing Twelve Months sales for Mirum Pharmaceuticals Inc [NASDAQ:MIRM] were 379.25M which represents 61.20% growth. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.2%, and Net Profit Margin reading is -0.2%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.34 and Total Capital is -0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.36.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 49.69 points at the first support level, and at 48.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 50.80, and for the 2nd resistance point, it is at 51.17.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Mirum Pharmaceuticals Inc [NASDAQ:MIRM] is 3.22. As well, the Quick Ratio is 3.04, while the Cash Ratio is 1.66. Considering the valuation of this stock, the price to sales ratio is 6.59, the price to book ratio is 10.69.
Transactions by insiders
Recent insider trading involved Fairey William, Director, that happened on Jun 11 ’25 when 3203.0 shares were sold. Director, WILLIAM C FAIREY completed a deal on Jun 11 ’25 to buy 3203.0 shares. Meanwhile, Director Ramasastry Saira sold 5703.0 shares on Jun 02 ’25.
